Table 1.
synthesis | cell viabilitya | ||
---|---|---|---|
analogue | Ar | % yield | GI50, μM |
8 | 83 | 0.33 ± 0.06 | |
9 | 87 | 0.58 ± 0.14 | |
10 | 88 | 1.1 ± 0.8 | |
11 | 75 | 2.7 ± 1.1 | |
12 | 83 | 3.5 ± 1.3 | |
13 | 84 | 6.4 ± 1.1 | |
14 | 97 | 6.5 ± 1.3 | |
15 | 98 | 18.3 ± 2.9 | |
16 | 97 | 43.3 ± 5.1 | |
17 | 81 | > 100 | |
18 | 97 | 35.0 ± 21.8 | |
19 | 87 | > 100 | |
20 | 80 | 22.7 ± 6.4 |
Concentration required to reduce the viability of HeLa cells by 50% after 48 h of treatment with indicated compounds relative to DMSO control ± SD from three independent experiments, each performed in 4 replicates, determined by MTT assay.